摘要
宫内节育器(IUD)是安全、有效、可逆的避孕方法,是我国女性常用的避孕措施。随着二孩政策开放,一些妇女使用宫内节育器避孕取出后出现了继发不孕的问题。放置宫内节育器对女性再生育的影响成为妇产科医生的关注焦点。本文围绕宫内节育器取出后的生育能力分别从宫内节育器与输卵管不孕、宫内节育器对子宫内膜的影响以及宫内节育器与不良妊娠等方面进行综述。
Intrauterine device(IUD)is a safe,effective and reversible method of contraception,which is commonly used by Chinese women.With the implementation of the universal two-child policy,some women have problems with secondary infertility after removal of IUD.The effect of placing an IUD on female fertility has become the focus of gynecologists.In this paper,women's fertility after removal of IUD is reviewed from the following three aspects:IUD and tubal infertility,influence of IUD on endometrium,IUD and adverse pregnancy outcomes.
引文
[1] Salem RM.New attention to the IUD:expanding women’s contraceptive options to meet their needs[J].Popul Rep B,2006(7):1-26.
[2]国家人口计生委发展规划司.人口和计划生育统计公报-2006年全国人口和计划生育抽样调查主要数据公报[R]..北京:国家人口和计划生育委员会,2007.
[3] Luchowski AT,Anderson BL,Power ML,et al.Obstetriciangynecologists and contraception:practice and opinions about the use of IUDs in nulliparous women,adolescents and other patient populations[J].Contraception,2014,89:572-577.
[4] Doll H,Vessey M,Painter R.Return of fertility in nulliparous women after discontinuation of the intrauterine device:comparison with women discontinuing other methods of contraception[J].BJOG,2001,108:304-314.
[5] Kavanaugh ML,Jerman J,Hubacher D,et al.Characteristics of women in the United States who use long-acting reversible contraceptive methods[J]. Obstet Gynecol,2011,117:1349-1357.
[6] Daling JR,Weiss NS,Metch BJ,et al.Primary tubal infertility in relation to the use of an intrauterine device[J].N Engl J Med,1985,312:937-941.
[7] Cramer DW,Schiff I,Schoenbaum SC,et al.Tubal infertility and the intrauterine device[J].N Engl J Med,1985,312:941-947.
[8] Ahmadnia E,Kharaghani R,Maleki A,et al.Prevalence and associated factors of genital and sexually transmitted infections in married women of Iran[J].Oman Med J,2016,31:439-445.
[9] Wang LY,OuYang L,Tong F,et al.The effect of contraceptive methods on reproductive tract infections risk:a cross-sectional study having a sample of 52,481women[J].Arch Gynecol Obstet,2016,294:1249-1256.
[10] Donders G,Bellen G,Janssens D,et al.Influence of contraceptive choice on vaginal bacterial and fungal microflora[J].Eur J Clin Microbiol Infect Dis,2017,36:43-48.
[11] Boisen AB,Ostenfeldt EB,Erikstrup LT,et al.Genital actinomycosis and pelvic abscesses in a woman with a 13-yearold intrauterine device[J].Ugeskr Laeger,2017,179.
[12] Erol O,Simavli S,Derbent A U,et al.The impact of coppercontaining and levonorgestrel-releasing intrauterine contraceptives on cervicovaginal cytology and microbiological flora:A prospective study[J].Eur J Contracept Reprod Health Care,2014,19:187-193.
[13] Tjernlund A,Carias AM,Andersson S,et al.Progesteronebased intrauterine device use is associated with a thinner apical layer of the human ectocervical epithelium and a lower ZO-1mRNA expression[J].Biol Reprod,2015,92:68.
[14] Cakiroglu Y,Caliskan S,Doger E,et al.Does removal of CUIUD in patients with biofilm forming candida really maintain regression of clinical symptoms?[J].J Obstet Gynaecol,2017,35:600-603.
[15] Dos Santos O,Rigo G V,Macedo AJ,et al.Trichomonas vaginalis clinical isolates:cytoadherence and adherence to polystyrene,intrauterine device,and vaginal ring[J].Parasitol Res,2017,116:3275-3284.
[16] Kancheva Landolt N,Chaithongwongwatthana S,Nilgate S,et al.Use of copper intrauterine device is not associated with higher bacterial vaginosis prevalence in Thai HIV-positive women[J].AIDS Care,2018,15:1-5.
[17] Bassis CM,Allsworth JE,Wahl HN,et al.Effects of intrauterine contraception on the vaginal microbiota[J].Contraception,2017,96:189-195.
[18] Songur Daqli S,Demir T.Comparison of cervico-vaginal colonization among sexually active women by intrauterine device use[J].J Infect Dev Ctries,2015,9:930-935.
[19] Donders GGG,Bellen G,Ruban K,et al.Short-and long-term influence of the levonorgestrel-releasing intrauterine system(Mirena(R))on vaginal microbiota and Candida[J].J Med Microbiol,2018,67:308-313.
[20] Madden T,Grentzer JM,Secura GM,et al.Risk of bacterial vaginosis in users of the intrauterine device:a longitudinal study[J].Sex Transm Dis,2012,39:217-222.
[21] Hubacher D,Lara-Ricalde R,Taylor DJ,et al.Use of copper intrauterine devices and the risk of tubal infertility among nulligravid women[J].N Engl J Med,2001,345:561-567.
[22] Terao M,Koga K,Fujimoto A,et al.Factors that predict poor clinical course among patients hospitalized with pelvic inflammatory disease[J].J Obstet Gynaecol Res,2014,40:495-500.
[23] Westr9m L.Effect of acute pelvic inflammatory disease on fertility[J].Am J Obstet Gynecol,1975,121:707-713.
[24] Caddy S,Yudin MH,Hakim J,et al.Best practices to minimize risk of infection with intrauterine device insertion[J].J Obstet Gynaecol Can,2014,36:266-274.
[25] Cakmak B,Ozalp SS,Acikalin MF,et al.Do leukaemia inhibitory factor and vascular endothelial growth factor have any roles in intrauterine device mechanism of action?An experimental rat study[J].Gynecol Obstet Invest,2015,81:181-185.
[26] Horcajadas JA,Sharkey AM,Catalano RD,et al.Effect of an intrauterine device on the gene expression profile of the endometrium[J].J Clin Endocrinol Metab,2006,91:3199-3207.
[27] Güney M,Oral B,Karahan N,et al.Expression of leukaemia inhibitory factor(LIF)during the window of implantation in copper T380Aintrauterine device users[J].Eur J Contracept Reprod Health Care,2007,12:212-219.
[28]辛志敏,谢青贞,曹路敏,等.放置宫内节育器对子宫内膜血管内皮生长因子及其激酶受体表达及微血管密度变化的影响[J].中华妇产科杂志,2004,39:771-775.
[29] Shanmugasundaram U,Hilton JF,Critchfield JW,et al.Effects of the levonorgestrel-releasing intrauterine device on the immune microenvironment of the human cervix and endometrium[J].Am J Reprod Immunol,2016,76:137-148.
[30] Hu LX,Wang H,Rao M,et al.Alterations in the endometrium of rats,rabbits,and Macaca mulatta that received an implantation of copper/low-density polyethylene nanocomposite[J].Int J Nanomedicine.,2014,9:1127-1138.
[31] Zhang S,Li Y,Yu P,et al.In vitro,release of cupric ion from intrauterine devices:influence of frame,shape,copper surface area and indomethacin[J].Biomed Microdevices,2015,17:19.
[32] Zhao X,Liu Q,Sun H,et al.Chronic systemic toxicity study of copper intrauterine devices in female wistar rats[J].Med Sci Monit,2017,23:3961-3970.
[33] Imani S,Moghaddam-Banaem L,Roudbar-Mohammadi S,et al.Changes in copper and zinc serum levels in women wearing a copper TCu-380Aintrauterine device[J].Eur J Contracept Reprod Health Care,2014,19:45-50.
[34] Chiesa-Vottero AG.Actinomycotic Endometritis[J].Int J Gynecol Pathol,2018:1-5.
[35]苏莉,游兰,黄洪萍.子宫内膜息肉宫腔镜切除术后发生宫腔黏连的相关因素分析[J].中国医学科学院学报,2017,39:812-816.
[36] Salma U,Xue M,Md Sayed AS,et al.Efficacy of intrauterine device in the treatment of intrauterine adhesions[J].Biomed Res Int,2014,2014:589296.
[37] Parashi S,Moukhah S,Ashrafi M.Main risk factors for ectopic pregnancy:a case-control study in a sample of Iranian women[J].Int J Fertil Steril,2014,8:147-154.
[38] Moini A,Hosseini R,Jahangiri N,et al.Risk factors for ectopic pregnancy:A case-control study[J].J Res Med Sci,2014,19:844-849.
[39] Zhang D,Shi W,Li C,et al.Risk factors for recurrent ectopic pregnancy:a case-control study[J].BJOG,2016,123:82-89.
[40] Heinemann K,Reed S,Moehner S,et al.Comparative contraceptive effectiveness of levonorgestrel-releasing and copper intrauterine devices:the European active surveillance study for intrauterine devices[J].Contraception,2015,91:280-283.
[41] Trussell J.Contraceptive failure in the United States[J].Contraception,2011,83:397-404.
[42] Ozgu-Erdinc AS,Tasdemir UG,Uygur D,et al.Outcome of intrauterine pregnancies with intrauterine device in place and effects of device location on prognosis[J].Contraception,2014,89:426-430.
[43] Stoddard AM,Xu H,Madden T,et al.Fertility after intrauterine device removal:A pilot study[J]. Eur J Contracept Reprod Health Care,2015,20:223-230.
[44] Abdinasab M,Dehghani Firouzabadi R,Farajkhoda T,et al.Lack of association between Cu T-380Aintrauterine device and secondary infertility in Iran[J].Int J Fertil Steril,2017,10:343-349.
